GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » Equity-to-Asset

PuriBlood Medical Co (ROCO:6847) Equity-to-Asset : 0.70 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. PuriBlood Medical Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was NT$168.7 Mil. PuriBlood Medical Co's Total Assets for the quarter that ended in Jun. 2024 was NT$241.0 Mil. Therefore, PuriBlood Medical Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.70.

The historical rank and industry rank for PuriBlood Medical Co's Equity-to-Asset or its related term are showing as below:

ROCO:6847' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31   Med: 0.72   Max: 0.82
Current: 0.7

During the past 6 years, the highest Equity to Asset Ratio of PuriBlood Medical Co was 0.82. The lowest was 0.31. And the median was 0.72.

ROCO:6847's Equity-to-Asset is ranked better than
63.16% of 228 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.59 vs ROCO:6847: 0.70

PuriBlood Medical Co Equity-to-Asset Historical Data

The historical data trend for PuriBlood Medical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co Equity-to-Asset Chart

PuriBlood Medical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.31 0.74 0.82 0.73 0.68

PuriBlood Medical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.71 0.73 0.71 0.68 0.70

Competitive Comparison of PuriBlood Medical Co's Equity-to-Asset

For the Diagnostics & Research subindustry, PuriBlood Medical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PuriBlood Medical Co's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PuriBlood Medical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where PuriBlood Medical Co's Equity-to-Asset falls into.



PuriBlood Medical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

PuriBlood Medical Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=181.161/265.512
=0.68

PuriBlood Medical Co's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=168.742/241.002
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PuriBlood Medical Co  (ROCO:6847) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


PuriBlood Medical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PuriBlood Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology provides protection to support living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Seperation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines